This compound is a bicyclic nucleoside analog, specifically a derivative of guanosine, characterized by the presence of a methylene bridge between the 2'-oxygen and 4'-carbon atoms of the ribose sugar. It serves as a pharmaceutical intermediate for the synthesis of nucleoside analogs.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 207131-16-6
((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl 4-methylbenzenesulfonate
pharmaceutical intermediate for nucleoside analogs
2'-Deoxy-2'-fluoroguanosine
pharmaceutical intermediate for nucleoside analogs
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
pharmaceutical intermediate for nucleoside analogs
Fmoc-Ala-OH H2O
Fmoc-protected amino acid for peptide synthesis
4-(Cbz-amino)piperidine Hydrochloride
Pharmaceutical intermediate
(2S)-4-[[(TERT-BUTOXY)CARBONYL]AMINO]-2-HYDROXYBUTANOIC ACID
Boc-protected amino acid intermediate
1,8-Bis(dimethylamino)naphthalene
Proton sponge for organic synthesis
2-amino-9-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-1H-purin-6-one
OZVMOEUWPMYRQU-JUQFDLSGSA-N
C1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)CO